Cargando…
Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer
BACKGROUND: The neddylation pathway is overactivated in human cancers. Inhibition of neddylation pathway has emerged as an attractive anticancer strategy. The mechanisms underlying neddylation overactivation in cancer remain elusive. MLN4924/Pevonedistat, a first-in-class NEDD8-activating enzyme (NA...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642072/ https://www.ncbi.nlm.nih.gov/pubmed/31208947 http://dx.doi.org/10.1016/j.ebiom.2019.06.005 |